Inactive
Notice ID:W81K0223P0126
The Medical Readiness Contract Office – Pacific, in support of Madigan Army Medical Center, Washington, intends to modify contract W81K0223P0126 with Sebia Inc to add 2 additional products and to adju...
The Medical Readiness Contract Office – Pacific, in support of Madigan Army Medical Center, Washington, intends to modify contract W81K0223P0126 with Sebia Inc to add 2 additional products and to adjust quantities for the following items, which are compatible with the Capillarys 3 Octa Analyzer for hemoglobin electrophoresis, serum electrophoresis, urine electrophoresis, serum immunotyping, carbohydrate deficient transferrin, and hemoglobin A1C testing: Adding: (1) High CDT Control (2) Tubes/Caps for Controls Adjusting Quantities: (1) CAPI 3 HBA1C (2) HBA1C Capillary Calibrators (3) CAPI 3 Bins for Reagent Cups (4) Reagent Cups for CAPI3 (5) CAPI 3 Wash Solution (6) CAPI 3 Protein(E) (7) Normal Control- Agarose/Capillary (8) Hypergamma Control Serum (9) CAPI 3 IT (10) CAPI 3 Urine (11) IT/IF Control (12) HB A2 Normal Control (13) Pathological HBA2 Control (14) HGB AFSC Control- Agarose/Capillarys (15) CAPI 3 CDT (16) HB A2 Normal Control (17) Clean Protect This contract was awarded via sole source procedures. The statutory authority permitting this award without providing full and open competition is FAR 13.501(a)(1)(ii) which authorizes the government to award contracts when there is only one responsible source and no other supplies or services will satisfy agency requirements. This announcement fulfills the synopsis requirements under FAR 5.201 and 5.203. This Notice of Intent is not a request for competitive quotes. Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential, or sensitive information should be included in your response.
